Document is current
Any future updates will be listed below
-
Authors
Pineda-Moncusí, Marta
Khan, Rabia Ali
Prats-Uribe, Albert
Prieto-Alhambra, Daniel
Khalid, Sara
- License Information
-
More Information
Article History
Received: 18 June 2024
Accepted: 5 March 2025
First Online: 4 April 2025
Declarations
:
: MPM, RAK and APU declare that there are no conflicts of interest. DPA’s department has received grant/s from Amgen, Chiesi-Taylor, Lilly, Janssen, Novartis, and UCB Biopharma. His research group has received consultancy fees from Astra Zeneca and UCB Biopharma. Amgen, Astellas, Janssen, Synapse Management Partners and UCB Biopharma have funded or supported training programmes organised by DPA’s department. SK is supported by the Innovative Medicines Initiative, Bill & Melinda Gates Foundation, Health Data Research UK, British Heart Foundation, Medical Research Council and Natural Environment Research Council outside of this work.
